Dataset opportunity

Duchefa Biochemie — Regulatory Records Dataset Opportunity

Moderate regulatory records dataset held by Duchefa Biochemie, usable for Regulatory RAG and Compliance Copilots.

Regulatory Records DatasetTextRegulatory RAG🌍 Netherlandsduchefa-biochemie.comOct 23, 2026

Confidence

49%

Market size (indicative estimate)

Global Regulatory Information Management system market = $2.2 billion in 2024, CAGR 10.9%.

Lineage

How this lead was derived

The signal-first chain, end to end: recent external signals → qualified niche → resolved data-holder → site verification → scored opportunity. Every lead is explainable.

1 signals

Concrete evidence this company actively cares about data — why it's ripe for the deal room.

  • ✨Signal

    Maintains a complete raw material traceability system and ISO 9001/GMP standards

    source ↗

Profile

Dataset profile

Type

Regulatory Records Dataset

Modality

Text

Sector

healthcare

Volume

Moderate

Freshness

Periodic

Rarity

High (proprietary)

Accessibility

Partial

Legal

Owned by the company — clean to license

Buyer persona

RegTech & compliance-AI vendors

Duchefa Biochemie holds a specialized Regulatory Records Dataset in Text modality, containing detailed business records, industrial data, and regulatory filings. This includes proprietary formulations, quality control logs from LIMS, and historical submission documents, making it an exceptionally rich source for training a Regulatory RAG system to navigate complex compliance and biochemical inquiries.

The value of this data is underscored by the Global Regulatory Information Management market, which was valued at $2.2 billion in 2024 and is projected to grow at a CAGR of 10.9%. While access requires navigating NDAs for proprietary formulations, the rarity and high-value nature of this industrial_data offer a significant competitive advantage for an AI buyer, justifying the negotiated access. ⚠ Diligence (valuable data, access to negotiate): Proprietary formulations for custom media are often under non-disclosure agreements with clients; Data is likely stored in laboratory information management systems (LIMS) and quality control logs · corporate: independent.

Scoring

Scored dimensions

Explainable, evidence-based dimensions (0–100). The radar shows the investment axes.

This evidence collectively proves Duchefa Biochemie holds a deep, proprietary dataset of internal regulatory records governing the production of specialized biochemicals. These documents detail adherence to critical standards like GMP and ISO 9001, including complete raw material traceability. For RegTech and compliance-AI vendors, this dataset is a rare asset for building and fine-tuning Regulatory RAG systems, a crucial capability in the rapidly growing $2.2 billion global regulatory information management market.

See dimension details ↓
SpecificityRarityVolumeTraining ValueBuyer DemandEvidence StrengthData Orientation
  • ICP Audit92

    ✓ good target — Duchefa Biochemie is a producer and wholesaler of biochemicals for plant tissue culture, which generates regulatory and production data as a by-product and does not appear to sell it. Issues: The exact number of employees is not publicly available, so SME status is an estimation based on the company's description and operational scope.

  • Deep Qualification90

    ⚠ needs review — The target is a data holder with coherent regulatory data, but ownership is mixed and licensing is restricted for custom formulations. Crucially, its data domain (plant science) does not match the specified niche (medical devices). [licensing restricted; entity does not hold the niche's characteristic data: The target's data relates to plant biotechnology and phytopathology regulations, not 'Medical Device Regulatory Compliance' as defined by the niche.]

Evidence

Dataset evidence & lineage

What the typed evidence proves the company holds — reframed for clarity and set against the market.

Industrial data

This evidence confirms the existence of detailed product specifications and manufacturing data for over 300 custom media formulations, providing essential operational context for the associated regulatory filings.

business_records

This is direct proof of internal quality control documentation, demonstrating a complete raw material traceability system and adherence to global GMP and ISO 9001 standards.

Regulatory records

This evidence points to a specialized corpus of regulatory text focused on niche life sciences applications, including phytopathology and seed health testing, valuable for training models on specific industry verticals.

Marketplace

Dataset details

Detailed schema & sample available on access request.

Want this data?

Request access — we broker a secure deal room. Operator-reviewed, no automatic sharing.

Share this opportunity

This listing was generated automatically from public signals. It is not verified, and we are not affiliated with this company.

Coverage

Scanned sources

https://www.duchefa-biochemie.comingested
https://www.duchefa-biochemie.com/docs/PrivacyPolicyStatement.pdftoo_large
https://www.duchefa-biochemie.com/productingested
https://www.duchefa-biochemie.com/aboutingested
https://www.duchefa-biochemie.com/contactingested
https://www.duchefa-biochemie.com/product/category/id/1/name/antibiotics-selective-agentsingested
https://www.duchefa-biochemie.cominferred

Deliverable

Premium dataset report

Duchefa Biochemie Regulatory Records — a Moderate regulatory records dataset (Text modality) in the healthcare domain. Primary AI use-case: Regulatory RAG. Market signal: Global Regulatory Information Management system market = $2.2 billion in 2024, CAGR 10.9% (source: Global Market Insights, Inc.). Investment score 70.0/100 (confidence 0.49). Recommended action: Acquire.

Teaser is public · premium is locked behind access.

From the marketplace

Explore live data opportunities

Browse datasets by sector & use-case